Franklin Resources Inc. decreased its position in shares of American Renal Associates Holdings Inc (NYSE:ARA) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 749,809 shares of the company’s stock after selling 4,522 shares during the period. Franklin Resources Inc.’s holdings in American Renal Associates were worth $13,046,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ARA. Van Berkom & Associates Inc. raised its position in American Renal Associates by 490.5% during the third quarter. Van Berkom & Associates Inc. now owns 2,191,863 shares of the company’s stock valued at $32,812,000 after purchasing an additional 1,820,649 shares in the last quarter. Acadian Asset Management LLC raised its position in American Renal Associates by 75.1% during the fourth quarter. Acadian Asset Management LLC now owns 206,928 shares of the company’s stock valued at $3,600,000 after purchasing an additional 88,748 shares in the last quarter. Citadel Advisors LLC raised its position in American Renal Associates by 306.8% during the fourth quarter. Citadel Advisors LLC now owns 54,254 shares of the company’s stock valued at $944,000 after purchasing an additional 40,917 shares in the last quarter. Dimensional Fund Advisors LP raised its position in American Renal Associates by 303.9% during the third quarter. Dimensional Fund Advisors LP now owns 50,027 shares of the company’s stock valued at $749,000 after purchasing an additional 37,641 shares in the last quarter. Finally, Alambic Investment Management L.P. raised its position in American Renal Associates by 84.0% during the fourth quarter. Alambic Investment Management L.P. now owns 81,350 shares of the company’s stock valued at $1,415,000 after purchasing an additional 37,130 shares in the last quarter. Institutional investors and hedge funds own 91.64% of the company’s stock.
A number of equities research analysts have weighed in on the company. Leerink Swann downgraded American Renal Associates from an “outperform” rating to a “market perform” rating and raised their price target for the company from $17.00 to $27.00 in a research report on Thursday, March 8th. Zacks Investment Research upgraded American Renal Associates from a “sell” rating to a “hold” rating in a research report on Tuesday, February 20th. Finally, SunTrust Banks set a $20.00 price target on American Renal Associates and gave the company a “buy” rating in a research report on Thursday, December 21st.
American Renal Associates (NYSE:ARA) last released its quarterly earnings data on Tuesday, March 6th. The company reported $0.18 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.15 by $0.03. The firm had revenue of $194.40 million for the quarter, compared to the consensus estimate of $195.15 million. American Renal Associates had a positive return on equity of 14.51% and a negative net margin of 1.00%. The company’s quarterly revenue was down 2.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.26 earnings per share. research analysts expect that American Renal Associates Holdings Inc will post 0.74 EPS for the current year.
WARNING: “Franklin Resources Inc. Lowers Holdings in American Renal Associates Holdings Inc (ARA)” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/3298734/franklin-resources-inc-lowers-holdings-in-american-renal-associates-holdings-inc-ara.html.
American Renal Associates Profile
American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.
Want to see what other hedge funds are holding ARA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Renal Associates Holdings Inc (NYSE:ARA).
Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.